Compounds > amidox
Page last updated: 2024-09-03

amidox and Leukemia L 1210

amidox has been researched along with Leukemia L 1210 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elford, HL; Findenig, G; Fritzer-Szekeres, M; Novotny, L; Szekeres, T; Vachalkova, A1
Elford, HL; Fritzer-Szekeres, M; Göbl, R; Novotny, L; Szekeres, T; Vachalkova, A1
Cory, JG; Elford, HL; Tihan, T1

Other Studies

3 other study(ies) available for amidox and Leukemia L 1210

ArticleYear
Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase.
    Life sciences, 1997, Volume: 61, Issue:22

    Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Humans; Hydroxamic Acids; Iron Compounds; Leukemia L1210; Leukemia, Erythroblastic, Acute; Mice; Oxidation-Reduction; Oximes; Polarography; Ribonucleotide Reductases; Tumor Cells, Cultured

1997
Iron binding capacity of didox (3,4 dihydroxybenzohydroxamic acid) and amidox (3,4 dihydroxybenzamidoxime) two inhibitors of the enzyme ribonucleotide reductase.
    Advances in experimental medicine and biology, 1998, Volume: 431

    Topics: Animals; Antineoplastic Agents; Cell Division; Enzyme Inhibitors; Humans; Hydroxamic Acids; Iron; Leukemia L1210; Mice; Oximes; Polarography; Ribonucleotide Reductases; Tumor Cells, Cultured

1998
Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
    Advances in enzyme regulation, 1991, Volume: 31

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cytidine; Deoxyribonucleotides; Hydroxamic Acids; Hydroxyurea; Kinetics; Leukemia L1210; Mice; Oximes; Ribonucleotide Reductases

1991